Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579280 · ClinicalTrials.gov registry record · Phase 4
Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
A Phase 4 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 224
- Enrollment target
NCT00579280 is a Phase 4 study that has completed, run by University of South Florida. The registered enrollment target is 224 participants.
The verdict
NCT00579280, a Phase 4 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 224 participants
- Enrollment target
Study Summary
The specific aim of this study is to evaluate the efficacy, tolerability, and safety of quetiapine SR monotherapy and divalproex sodium ER monotherapy in comparison to placebo in the treatment of ambulatory bipolar disorder with co-morbid lifetime panic disorder or generalized anxiety disorder and current at least moderately severe anxiety.
Interventions
- DRUG placebo
- DRUG divalproex sodium ER
- DRUG quetiapine SR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579280
The ClinicalTrials.gov registry entry for NCT00579280 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00579280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579280 about?
NCT00579280 is a clinical study titled "Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD". The specific aim of this study is to evaluate the efficacy, tolerability, and safety of quetiapine SR monotherapy and divalproex sodium ER monotherapy in comparison to placebo in the treatment of ambulatory bipolar disorder with co-morbid lifetime panic disorder or generalized anxiety disorder and c...
What is the current status of trial NCT00579280?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 224 participants. The study started on 2007-07. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00579280?
The interventions under investigation include: placebo (DRUG), divalproex sodium ER (DRUG), quetiapine SR (DRUG).
Who is sponsoring clinical trial NCT00579280?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.